These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 9442365)

  • 1. Cardiovascular effects of L-arginine.
    Maxwell AJ; Cooke JP
    Curr Opin Nephrol Hypertens; 1998 Jan; 7(1):63-70. PubMed ID: 9442365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical pharmacology of L-arginine.
    Böger RH; Bode-Böger SM
    Annu Rev Pharmacol Toxicol; 2001; 41():79-99. PubMed ID: 11264451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nitric oxide synthase inhibition and oxidative stress in cardiovascular diseases: possible therapeutic targets?
    Rochette L; Lorin J; Zeller M; Guilland JC; Lorgis L; Cottin Y; Vergely C
    Pharmacol Ther; 2013 Dec; 140(3):239-57. PubMed ID: 23859953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [L-Arginine and vascular health].
    Ströhle A; von Bibra H; Hahn A
    Med Monatsschr Pharm; 2016 Dec; 39(12):515-20. PubMed ID: 29979511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cellular and physiological effects of arginine.
    Tong BC; Barbul A
    Mini Rev Med Chem; 2004 Oct; 4(8):823-32. PubMed ID: 15544543
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic modification of the L-arginine-eNOS pathway in cardiovascular diseases.
    Goumas G; Tentolouris C; Tousoulis D; Stefanadis C; Toutouzas P
    Atherosclerosis; 2001 Feb; 154(2):255-67. PubMed ID: 11166757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Arginine and nitric oxide synthase: regulatory mechanisms and cardiovascular aspects.
    Lorin J; Zeller M; Guilland JC; Cottin Y; Vergely C; Rochette L
    Mol Nutr Food Res; 2014 Jan; 58(1):101-16. PubMed ID: 23740826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Asymmetric dimethylarginine and endothelial dysfunction].
    Yoshizumi M
    Nihon Rinsho; 2004 Sep; 62 Suppl 9():555-60. PubMed ID: 15506448
    [No Abstract]   [Full Text] [Related]  

  • 9. L-Arginine, the substrate for NO synthesis: an alternative treatment for premature atherosclerosis?
    Siasos G; Tousoulis D; Antoniades C; Stefanadi E; Stefanadis C
    Int J Cardiol; 2007 Apr; 116(3):300-8. PubMed ID: 16860889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-Arginine improves vascular function by overcoming deleterious effects of ADMA, a novel cardiovascular risk factor.
    Böger RH; Ron ES
    Altern Med Rev; 2005 Mar; 10(1):14-23. PubMed ID: 15771559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Arginase Inhibition Restores Peroxynitrite-Induced Endothelial Dysfunction via L-Arginine-Dependent Endothelial Nitric Oxide Synthase Phosphorylation.
    Nguyen MC; Park JT; Jeon YG; Jeon BH; Hoe KL; Kim YM; Lim HK; Ryoo S
    Yonsei Med J; 2016 Nov; 57(6):1329-38. PubMed ID: 27593859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arginase as a potential target in the treatment of cardiovascular disease: reversal of arginine steal?
    Pernow J; Jung C
    Cardiovasc Res; 2013 Jun; 98(3):334-43. PubMed ID: 23417041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of L-arginine and L-nitro-arginine methyl ester on recovery of neonatal lamb hearts after cold ischemia. Evidence for an important role of endothelial production of nitric oxide.
    Hiramatsu T; Forbess JM; Miura T; Mayer JE
    J Thorac Cardiovasc Surg; 1995 Jan; 109(1):81-6; discussion 87. PubMed ID: 7529348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway.
    Shen LJ; Beloussow K; Shen WC
    Biochem Pharmacol; 2005 Jan; 69(1):97-104. PubMed ID: 15588718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. L-Arginine therapy in cardiovascular pathologies: beneficial or dangerous?
    Böger RH
    Curr Opin Clin Nutr Metab Care; 2008 Jan; 11(1):55-61. PubMed ID: 18090660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic use of citrulline in cardiovascular disease.
    Romero MJ; Platt DH; Caldwell RB; Caldwell RW
    Cardiovasc Drug Rev; 2006; 24(3-4):275-90. PubMed ID: 17214603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. L-arginine-dependent nitric oxide synthase: a new metabolic pathway in the lung and airways.
    Jorens PG; Vermeire PA; Herman AG
    Eur Respir J; 1993 Feb; 6(2):258-66. PubMed ID: 7680323
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of L-arginine on the endogenous angiogenic response in a model of hypercholesterolemia.
    Nakai Y; Voisine P; Bianchi C; Xu SH; Feng J; Malik T; Rosinberg A; Sellke FW
    Surgery; 2005 Aug; 138(2):291-8. PubMed ID: 16153439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arginine and endothelial and vascular health.
    Gornik HL; Creager MA
    J Nutr; 2004 Oct; 134(10 Suppl):2880S-2887S; discussion 2895S. PubMed ID: 15465805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of nitric oxide synthase (NOS) conversion of L-arginine to nitric oxide (NO) decreases low density mononuclear cell (LD MNC) trans-endothelial migration and cytokine output.
    Isenberg JS
    J Surg Res; 2003 Sep; 114(1):100-6. PubMed ID: 13678705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.